-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-f1-surveillance-report-1.xlsx
November 22, 2021 - Title
Appendix F - Data Abstraction of Efficacy Outcomes
NPP_Pain
Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseli…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-251-integrated-pain-management-evidence-summary.pdf
October 01, 2021 - Intergrated and Comprehensive Pain Management Programs: Effectiveness and Harms: Evidence Summary
Comparative Effectiveness Review
Number 251
Integrated and Comprehensive Pain
Management Programs: Effectiveness and
Harms
Evidence Summary
Main Points
Background and Purpose
Pain affects millions …
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_executive.pdf
March 01, 2016 - Nonpharmacologic interventions aim to (1) prevent
agitation/aggression, (2) respond to episodes of agitated … Interventions designed to respond
to a behavior are different from those designed to prevent
the occurrence … Interventions designed to respond to a
behavior are different from those designed to prevent the
occurrence … general stance that
agitation/aggression is communication that caregivers need
to try to decipher and respond
-
effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - CER #13:
Comparative Effectiveness of Therapies for Clinically
Localized Prostate Cancer
Original release date:
February 2008
Surveillance Report:
May 2012
Key Findings:
• The PIVOT trial was identified, making many of the
existing key conclusions out of date.
• Key questions 1, 2, and 4 were found t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - CER #13:
Comparative Effectiveness of Therapies for Clinically
Localized Prostate Cancer
Original release date:
February 2008
Surveillance Report:
May 2012
Key Findings:
• The PIVOT trial was identified, making many of the
existing key conclusions out of date.
• Key questions 1, 2, and 4 were found t…
-
effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
January 01, 2012 - Participants are
required to respond to all parameters. … symptoms’ underlying inflammation and are costly.
1
From 10% to 40% of patients with
UC fail to respond … treatments (sulfasalazine, olsalazine, mesalamine).
10
For patients with severe UC, or
UC that fails to respond
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Participants are
required to respond to all parameters. … responsiveness than other children do, display no positive affect for toys and
activities, and may respond
-
effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment/research-protocol
December 20, 2011 - Current Page Topic Timeline Sep. 6, 2011 Topic Initiated Dec. 20, 2011 Research Protocol Apr. 3, 2013 Systematic Review Jul. 31, 2013 Disposition of Comments Report Psychological Treatments and Pharmacological Treatments for Adults with Post-traumatic Stress Disorder (PTSD)
Research Protocol Archived December 20, …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
September 20, 2022 - NPP_Pain
Table F-1a. Pain severity for neuropathic pain
Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Participants are
required to respond to all parameters.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
October 29, 2012 - CER # 48:
Hematopoietic Stem-Cell Transplantation in the Pediatric
Population
Original release date:
February 01, 2012
Surveillance Report:
October 29, 2012
Key Findings:
• KQ1, 2, 3, 4, 5 and 6 up to date
• Expert opinion: conclusions still valid
• There are no new significant safety co…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-adult-patients-with-bipolar-disorder-including-bipolar-i-and-bipolar-ii-disorder-what-is-the-comparative-effectiveness-of-available-treatments-including-psychotherapy-other-psychosocial-treatments-medications-and-other-so
April 22, 2013 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description
Topic Suggestion Description
Date submitted: April 22, 2013
Download Topic Suggestion Disposition [PDF · 1.2 MB]
Briefly describe a specific question, or set of related questions, about a health ca…
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
January 01, 2011 - Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA)
Slide 1
Integrating stakeholder preferences in comparative effectiveness research using
multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA)
Maarten J…
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
August 27, 2012 - The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints
Slide 1
The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment
Endpoints
F. Reed Johnson, PhD
Distinguished Fellow and Principal Economist
Research Triangle Institute
Integrating Stakehold…
-
effectivehealthcare.ahrq.gov/sites/default/files/mccullough.pdf
January 01, 2011 - McCullough
Slide
1: An Ethical Framework for Supporting
Shared Decision Making
When Clinical
Evidence is Low
Laurence B. McCullough, Ph.D.
Dalton Tomlin Chair in Medical Ethics and Health Policy
Associate Director for Education
Center for Medical Ethics and
…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-2.pdf
May 15, 2023 - March 2nd Mitigating Racial Bias in Healthcare Algorithms Public Meeting
Impact of Healthcare Algorithms on Racial and
Ethnic Disparities in Health and Healthcare
March 2, 2023
10:30 a.m.- 3:40 p.m. ET
Welcome
Prashila Dullabh, MD
NORC
Racial Bias and Healthcare Algorithms
March 2, 2023
10:30–10:35 a.m. ET
…
-
effectivehealthcare.ahrq.gov/products/collections/covid-resources
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - i
CER # 17:
Comparative Effectiveness of Medications To Reduce Risk of
Primary Breast Cancer in Women
Original release date:
September 14, 2009
Surveillance Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: July, 2012
Key Findings:
• 2 of 6 conclusions for Key Question 1, …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease-future_research.pdf
July 01, 2016 - clinical setting; (d) identifying treatments to induce and
maintain remission in patients who do not respond
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
September 20, 2022 - NPP_Pain
Table F-1a. Pain severity for neuropathic pain
Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…